logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 865 2352511, +7 865 2353229.

E-mail
medvestnik@stgmu.ru

Crohn’s disease: features of diagnosis and choice of treatment tactics in presence of sacroiliitis

[Notes from practice]
Alena Vasilievna Aparkina; Elena Igorevna Kashkina; Rimma Vladimirovna Lyakisheva;

The article presents the clinical observation of patient with Crohn’s disease, for verification of whose diagnose was required difficult differential diagnosis with appendicular infiltrate. In the future, the progression of intestinal symptoms, as well as the signs of bilateral sacroiliitis, despite the standard basic therapy, necessitated the appointment of a genetically engineered drug that contributed to the rapid relief of all clinical manifestations of the disease.

Download

References:
1. Kuzin A. V., Rumyantcev V. G. Arthritis associated with the inflammatory intestinal diseases. Dokazatel’naya gastroenterologiya. – Evidence-based gastroenterology. 2014;3(2):32-35. (In Russ.).
2. Lukina G. V., Kulakova P. I., Novikov A. A., Alexandrova E. A., Savenkova N. A. [et al.]. Frequency of inflammatory bowel diseases in patients with ankylosing spondylitis. Medicinskij alfavit. Seriya «Revmatologiya v obshchej vrachebnoj praktike». – Medical alphabet. Series «Rheumatology in general medical practice». 2019;37(412):12-15. (In Russ.). https://doi.org/10.33667/2078-5631-2019-2-37(412)-12-15
3. Belyayeva I. B., Mazurov V. I. Treatment of arthritis and spondylitis during inflammatory bowel disease: rational approaches and errors. Effektivnaya farmakoterapiya. – Effective pharmacotherapy. 2017;12:40-43. (In Russ.).
4. Paraskevi V. Rheumatological manifestations in inflammatory bowel disease. Ann. Gastroenterol. 2011;24(3):173-180.
5. Ivashkin V. T., Shelygin Yu. A., Khalif I. L., Belousova E. A., Shifrin O. S. [et al.]. Clinical guide of Russian association of gastroenterology and Russian Association of coloproctology on diagnostics and treatment of Crohn’s disease. Koloproktologiya. – Coloproctology. 2017;60(2):7-29. (In Russ.).
6. Pouillon L., Bossuyt P., Vanderstukken J., Moulin D., Netter P. [et al.]. Management of patients with inflammatory bowel disease and spondyloarthritis. Expert Rev. Clin. Pharmacol. 2017;10(12):1363-1374. https://doi.org/10.1080/17512433.2017.1377609
7. Fagerli K. M., van der Heijde D., Heiberg M. S., Kalstad S., Rodevand E. [et al.]. Is there a role for sulphasalazine in axial spondyloarthritis in the era of TNF inhibition? Data from the NOR-DMARD longitudinal observational study. Rheumatology (Oxford, England). 2014;53:1087-1094. https://doi.org/10.1093/rheumatology/ket450
8. Leclerc-Jacob S., Lux G., Rat A. C., Laurent V., Blum A. [et al.]. The prevalence of inflammatory sacroiliitis assessed on magnetic resonance imaging of inflammatory bowel disease: a retrospective study performed on 186 patients. Aliment. Pharmacol. Ther. 2014;39:957-962. https://doi.org/10.1111/apt.12680

Keywords: Crohn’s disease, sacroiliitis, intestinal manifestations


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy